Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Wagner

Showing results (231-240 of 355) with videos related to

Pageof 36
Sort By:
Psycho-Oncology|December 5, 2022
Validation of the Lee-Jones theoretical model of fear of cancer recurrence among breast cancer survivors using a structural equation modeling approachAlexander R Lucas, Jun-Hao Pan, Edward H Ip, et al.
JMIR Formative Research|January 10, 2023
Adaptation of a Personalized Electronic Care Planning Tool for Cancer Follow-up Care: Formative StudyStephanie J Sohl, Pamela W Duncan, Elyse Thakur, et al.
ACS Nano|January 28, 2026
Urazole-Functionalized Carbon Nanotubes as Artificial DNA Strands and Their <i>In Vivo</i> ToxicityShwu-Chen Tsay, Deepa R Landge, Wen-Chieh Huang, et al.
JCO Oncology Practice|December 6, 2022
Oncologist-Reported Barriers and Facilitators to Enrolling Patients in Optimization Trials That Test Less Intense Cancer TreatmentGabrielle B Rocque, Courtney Andrews, Valerie M Lawhon, et al.
Cancer|October 16, 2012
Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 yearsAmye J Tevaarwerk, Robert J Gray, Bryan P Schneider, et al.
ACS Applied Materials & Interfaces|January 28, 2025
Oxygen Incorporation as a Route to Nondegenerate Zinc Nitride Semiconductor Thin FilmsElise Sirotti, Bianca Scaparra, Stefan Böhm, et al.
Cancer|May 30, 2026
Impact of patient-reported taxane-induced peripheral neuropathy on dose reductions or worsening quality of life in Black women with breast cancer: Analysis from ECOG-ACRIN EAZ171Tarah J Ballinger, Fengmin Zhao, Guanglong Jiang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805Wendy J Bottinor, Yael Flamand, Naomi B Haas, et al.
Journal of Pain and Symptom Management|October 26, 2007
Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practiceZeeshan Butt, Lynne I Wagner, Jennifer L Beaumont, et al.
JAMA Oncology|June 17, 2021
Association of Modifiable Risk Factors With Early Discontinuation of Adjuvant Endocrine Therapy: A Post Hoc Analysis of a Randomized Clinical TrialBetina Yanez, Robert J Gray, Joseph A Sparano, et al.
Pageof 36

Showing results (231-240 of 355) with videos related to

Sort By:
Pageof 36
Psycho-Oncology|December 5, 2022
Validation of the Lee-Jones theoretical model of fear of cancer recurrence among breast cancer survivors using a structural equation modeling approachAlexander R Lucas, Jun-Hao Pan, Edward H Ip, et al.
JMIR Formative Research|January 10, 2023
Adaptation of a Personalized Electronic Care Planning Tool for Cancer Follow-up Care: Formative StudyStephanie J Sohl, Pamela W Duncan, Elyse Thakur, et al.
ACS Nano|January 28, 2026
Urazole-Functionalized Carbon Nanotubes as Artificial DNA Strands and Their <i>In Vivo</i> ToxicityShwu-Chen Tsay, Deepa R Landge, Wen-Chieh Huang, et al.
JCO Oncology Practice|December 6, 2022
Oncologist-Reported Barriers and Facilitators to Enrolling Patients in Optimization Trials That Test Less Intense Cancer TreatmentGabrielle B Rocque, Courtney Andrews, Valerie M Lawhon, et al.
Cancer|October 16, 2012
Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 yearsAmye J Tevaarwerk, Robert J Gray, Bryan P Schneider, et al.
ACS Applied Materials & Interfaces|January 28, 2025
Oxygen Incorporation as a Route to Nondegenerate Zinc Nitride Semiconductor Thin FilmsElise Sirotti, Bianca Scaparra, Stefan Böhm, et al.
Cancer|May 30, 2026
Impact of patient-reported taxane-induced peripheral neuropathy on dose reductions or worsening quality of life in Black women with breast cancer: Analysis from ECOG-ACRIN EAZ171Tarah J Ballinger, Fengmin Zhao, Guanglong Jiang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805Wendy J Bottinor, Yael Flamand, Naomi B Haas, et al.
Journal of Pain and Symptom Management|October 26, 2007
Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practiceZeeshan Butt, Lynne I Wagner, Jennifer L Beaumont, et al.
JAMA Oncology|June 17, 2021
Association of Modifiable Risk Factors With Early Discontinuation of Adjuvant Endocrine Therapy: A Post Hoc Analysis of a Randomized Clinical TrialBetina Yanez, Robert J Gray, Joseph A Sparano, et al.
Pageof 36